| Particulars |
|
|
|
|
Company Name
| Caplin Point Laboratories Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
15.20 |
B.V. (₹) |
269.80 |
| Sales(₹ Cr.) |
738.33 |
NP (₹ Cr.) |
396.58 |
| NP Var% |
17.00 |
Div% |
200.00 |
| CPS(₹) |
55.50 |
EPS (₹) |
52.20 |
| Traded Value(₹ Lakhs) |
524.79 |
52 Week High |
2,587.00 |
| 52 Week Low |
1,502.00 |
Price BSE |
2,558.00 |
| Price NSE |
2,558.00 |
Market Capital (₹ Cr.) |
19,446.83 |
| P/C Ratio |
46.10 |
P/E Ratio |
49.00 |
| Price Vs.BV |
9.48 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
191.36 |
| NP(₹ Cr.) |
109.50 |
NP Var % |
27.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
665.78 |
| OPM |
45.14 |
NP |
303.61 |
| NP Var% |
16.70 |
EPS |
52.17 |
| PE |
49.04 |
|
|